CorMedix
CRMD • NASDAQ
CorMedix is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joseph Todisco, with a market cap of $581.8M.
Market Cap$581.8M
Employees82.0
CEOJoseph Todisco
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
CorMedix FAQ
Common questions about CorMedix
CorMedix is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $106.9M.
CorMedix has approximately 82 employees.